3 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Fractionated Stereotactic Radiation Therapy: new trials by email Literature Review of Fractionated Stereotactic Radiation Therapy trials Research Report on Fractionated Stereotactic Radiation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma Patient Observation, Magnetic Resonance Imaging, Biospecimen Collection - Grade 1 Meningioma, Grade 2 Meningioma | Phase 3 | Not yet recruiting | NRG Oncology | 464 | 2027-01-28 | 2026-08-25 |
| Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma Hypofractionated Stereotactic Radiosurgery (SRS), Magnetic Resonance Imaging (MRI), Computed Tomography (CT) - Meningioma, Meningioma, Malignant | Not applicable | Recruiting | University of California, San Francisco | 23 | 2024-12-13 | 2026-08-26 |
| Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain Computed Tomography, Fractionated Stereotactic Radiation Therapy, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 3 | Active not recruiting | NRG Oncology | 274 | 2024-12-12 | 2026-09-14 |
| Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma Atezolizumab, Biospecimen Collection, Conventional Surgery - Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 61 | 2022-03-11 | 2026-09-23 |
| Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Etoposide - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Active not recruiting | City of Hope Medical Center | 52 | 2021-04-30 | 2026-07-13 |
Astrocytoma (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Glioblastoma (1) · Hematologic Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Meningioma (1) · Neoplasm Metastasis (1)
NRG Oncology (2) · City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · University of California, San Francisco (1)
United States (4) · Canada (1) · Hong Kong (1) · Ireland (1)
Karamjeet S Sandhu (1) · Rupesh R Kotecha (1) · Stephen J Bagley (1) · William Chen, MD (1)
U10CA180868 (2)